Kezar Life Sciences' Series B Round

Kezar Life Sciences raised a round of funding on July 25, 2017.

Kezar Life Sciences (NASDAQ: KZR) was founded in 2015 to develop drugs to revolutionize the treatment of autoimmune disorders. Leveraging research begun in 2006 under the direction of co-founder Dr. K…

Articles about Kezar Life Sciences' Series B Round: